AzTrials
AzTrials

Intraoperative AwarenessNCT03571945

Incidence of Intraoperative Awareness in Indian Patient Population

A study testing Bi-spectral Index (BIS QUATRO REF #186-0106) and End tidal anaesthesia gas concentration (ETAG) in people with Intraoperative Awareness, run by Sir Ganga Ram Hospital at 5 sites in India.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

The profiling of bi-spectral index (BIS) monitored facilitation of general anesthesia (GA), including, anesthesia induction and maintenance of GA depth state, emergence characteristics, and postoperative recovery parameters, is now extensively available. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Intraoperative Awareness
What is being tested?
Bi-spectral Index (BIS QUATRO REF #186-0106) and End tidal anaesthesia gas concentration (ETAG)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,000 participants
Where
5 sitesIndia
Study dates
10 Oct 2018to 2 Mar 2028
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Male or female gender
  • Aged 18-65 yrs.
  • ASA Physical Status I/II
  • General Anaesthesia
  • Elective Surgery
  • Surgery duration > 30-minutes
  • Consenting for follow-up

Who cannot join

  • Uncompensated systemic co-morbidity
  • Cardiac and Neurosurgical procedures
  • Head \& Neck surgery
  • Obstetric surgery
  • Emergency surgery
  • Anticipated difficult airway
Show all 12Show fewer
  • H/O brain injury, EEG abnormality
  • Neuropsychiatry disorders
  • Substance abuse (opioids, alcohol, recreational drugs, benzodiazepine)
  • Pacemakers \& Electronic implants
  • Obesity (BMI>30kg/m2)
  • Adhesive allergy

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

India5 sites
  • Post Graduate Institute For Medical Education & Research

    Chandigarh

  • Prof. L Parthasarathy

    Chennai, Tamil Nadu, 600002

  • Apollo Gleneagles Hospital

    Kolkata, 700054

  • P D Hinduja Hospital & Medical Research Centre

    Mumbai

  • Sir Ganga Ram Hospital

    New Delhi, National Capital Territory of Delhi, 110060

Other trials in India

About this study

Official title: Impact of Bi-spectral Index Guided Inhalation Anaesthesia on the Incidence of Intraoperative Awareness in Indian Patient Population: A Prospective, Randomised, Multi-Centric Study

The profiling of bi-spectral index (BIS) monitored facilitation of general anesthesia (GA), including, anesthesia induction and maintenance of GA depth state, emergence characteristics, and postoperative recovery parameters, is now extensively available. However, majority of the data supporting the use of BIS have emanated from western Caucasian patient population. Though research on BIS monitoring have also emerged from Asian subcontinent, the data generated, at the best, is too scattered, random, and non-homogenous to reflect onto how BIS guidance fares in Asians on a population basis. We aim to undertake a multi-centric prospective cohort trial in Asian patient population to analyze as to whether BIS guidance toes the profiling and the evidence in Caucasians.

Read the detailed description

After Institutional Ethics Committee approval and informed written patient consent, 2000 patients justifying inclusion and exclusion criteria ( will be included in this National, multi-centric, prospective, randomised, double-blind (patients, analyst), 2- arm trial.

All the patients scheduled for elective surgery under general anaesthesia will be randomly (simple computer generated random number table) allocated to one of the following two groups:

Group I [BIS Guided Group, n=1000]: GA will be monitored and controlled with Bi-spectral index (BIS).

Group II [ETAG Guided Group, n=1000]: GA will be monitored and controlled with end-tidal anaesthesia gas concentration (ETAG).

Sample Size Estimation To detect a difference in incidence of awareness of 0.04 % (a rate based on Mashour et al, Anesthesiology 2012) between the ETAG and BIS-guided group a total of 1800 patients will be required at a power of 80% with a type-II error 0f 0.5. To compensate for possible drop outs 10% additional patients will be recruited for the study. Therefore, the total sample size will include 2000 patients.

Randomization concealment: will be done using opaque sealed envelopes with alphabetic codes. In addition, before opening the envelope patient's data slip will be pasted on the envelopes.

Blinding: Investigator, assessor and the data analyst will be blinded to the method of GA (BIS or ETAG guided) Subgroup Analysis: Subgroup analysis will be specifically performed and reported if the data shows gender equivalence (i.e., at least 40% patients of either sex in each group).

Anaesthesia Technique:

Routine monitoring (EtCO2, pulse oximetery, EKG, NIBP) will be applied during the procedure. Anaesthesia will be induced with fentanyl 2-mcg/kg and propofol 1.5-2.5 mg/kg. Non-depolarizing muscle relaxant (vecuronium/ rocuronium/ atracurium) will be administered to facilitate tracheal intubation. GA will be maintained with inhalation regimen (sevoflurane/desflurane-oxygen-air mixture) to target age-related MAC range of 0.7 to 1.3. Corresponding BIS score and end-tidal agent concentration will be noted at 5-minute interval. While, in the BIS group the anaesthesiologist will be blinded to ETAG and MAC readings, in the ETAG group BIS display will be turned off. However, ETAG and MAC data will both be analyzed once the study is over. Although, the MAC will be titrated to haemodynamic goals (+20% baseline of SBP/MAP/Heart rate), it will be maintained within the prescribed range. On either side of the range of MAC, the haemodynamic depression/ activation will be responded to with vasopressor/vasodilators. At the end of surgery inhalation agent delivery will be stopped. The residual neuromuscular blockade will be reversed with neostigmine and glycopyrrolate.

The patients will be extubated once wide-awake and following commands. ASSESSMENT PARAMETERS Analysis of Intraoperative Awareness Quantitative: The participants will be subjected to modified Brice Interview 20 24-hours after surgery and after one month. The Brice interview at one month will be undertaken through telephonic contact and if awareness is present on any or both the occasions, a three-member independent awareness committee will review the incidence intensively. The awareness will be adjudicated in broad divisions, including, definite, possible, and no awareness. 21 No Awareness: No awareness or a perception of awareness that has a high probability of occurrence in the preoperative and the postoperative period.

Possible Awareness: There is a perception of awareness but the patient is unable to recall any event definitive indicative of awareness.

Definite Awareness: Perception of awareness that has clear recall or has a high likelihood of occurring in the intraoperative period.

Qualitative: After adjudication of a definite awareness by the awareness committee, the participants will be classified on the awareness pattern using the Michigan awareness classification instrument. 21 Class 1 will be defined by isolated auditory perception, Class 2 by tactile perceptions, Class 3 by pain experience, Class 4 by a feeling of paralysis and helplessness to move, and Class 5 by the presence of both paralysis and pain. If the awareness event is associated with distress the class will be modified with a suffix "D".

If definite awareness is present, the participants will be offered counselling sessions to ward off long-term behavioral changes and post-traumatic stress disorder (PTSD) The inter-reviewer observation will be analyzed for agreement using Fleiss's Kappa statistics for blinded assessment.

BIS score and end-tidal inhalation agent concentration: The intraoperative BIS scores and end-tidal inhalation agent concentration will be noted (every 5-minutes).

Time to awakening and tracheal extubation: Time (in minutes) to awakening will be noted after discontinuation of anaesthesia to point of first spontaneous eye opening. The time will be confirmed by the ability of the patient to obey commands. Time (in minutes) to tracheal extubation will comprise of the period after discontinuation of anaesthesia to tracheal extubation.

Statistical Analysis:

Demographic and procedural data will be analyzed with student's t-test, double sided, or the Chi-square test with Yate's correction as appropriate. Analysis of awareness outcome will be performed using Fisher's exact test. Sensitivity and specificity analysis will be undertaken for BIS values vis-à-vis explicit recall or no recall.

Being tested
Bi-spectral Index (BIS QUATRO REF #186-0106), End tidal anaesthesia gas concentration (ETAG)
Medical subject headings
Intraoperative Awareness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Bi-spectral Index (BIS QUATRO REF #186-0106)Device

    GA will be monitored and controlled with Bi-spectral index (BIS).

  • End tidal anaesthesia gas concentration (ETAG)Device

    GA will be monitored and controlled with end-tidal anaesthesia gas concentration

Study groups in NCT03571945
Study groupRoleWhat they receive
BIS Guided GroupActive comparatorGA will be monitored and controlled with Bi-spectral index (BIS) monitoring.The anaesthesiologist will be blinded to ETAG and MAC readings.
Receives: Device: Bi-spectral Index (BIS QUATRO REF #186-0106)
ETAG Guided GroupActive comparatorGA will be monitored and controlled with end-tidal anaesthesia gas (ETAG) monitoring.The anaesthesiologist will be blinded to the BIS readings.
Receives: Device: End tidal anaesthesia gas concentration (ETAG)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of intraoperative awareness

    Will be assessed using Modified Brice Interview and Michigan awareness classification instrument

    Measured: From end of anaesthesia till 30-days postoperatively

Secondary outcomes (10)
  1. Intraoperative Bi-spectral index (BIS) score

    BIS values will be recorded from the patient monitor

    Measured: From beginning of anaesthesia (0-hours, baseline) till 8 hours intraoperatively

  2. Intraoperative End-tidal anaesthesia gas (ETAG) concentration

    ETAG concentration will be recorded from the patient monitor

    Measured: From beginning of anaesthesia (0-hours, baseline) till 8 hours intraoperatively

  3. Intraoperative minimum alveolar concentration (MAC)

    MAC will be recorded from the patient monitor

    Measured: From beginning of anesthesia (0-hours, baseline) till 8 hours intraoperatively

  4. Recovery from anaesthesia

    Time taken by the patient to open his/her eyes after discontinuation of anaesthesia will be noted

    Measured: From end of anaesthesia till 20-minutes postoperatively

  5. Recovery from anaesthesia

    Time taken for tracheal extubation after discontinuation of anaesthesia will be noted

    Measured: From end of anaesthesia till 20-minutes postoperatively

  6. Changes in intra-operative heart rate (beats per minute)

    Comparison of intra-operative heart rate between both the arms will be done

    Measured: From beginning of anesthesia (0-hours, baseline) till 8 hours intra-operatively

  7. Change in Intra-operative blood pressure - systolic , diastolic, and mean (mmHg)

    Comparison of intra-operative blood pressure- systolic, diastolic, and mean between both the arms will be done

    Measured: From beginning of anaesthesia (0-hours, baseline) till 8 hours intraoperatively]

  8. Postoperative Sedation

    Will be assessed using Modified Observer's assessment of alertness/sedation scale (OASS). This scale measures postoperative sedation on a scale of 0 to 5. A score of '0' indicates patient is deeply sedated with no response to any stimuli , whereas a score of 5 indicates that the patient is wide awake.

    Measured: From end of anaesthesia till 24-hours postoperatively]

  9. Postoperative Nausea and Vomiting (PONV)

    Will be assessed using postoperative nausea and vomiting (PONV) Scale. The scale measures PONV on a scale of 0 to 2. A score of '0' indicates that the patient has no emetic symptoms, whereas a score of '2' indicates that the patient has vomiting.

    Measured: From end of anaesthesia till 24-hours postoperatively]

  10. Postoperative Analgesia

    Will be assessed using 10-point Visual Analogue Scale (VAS) Score which measures pain on a scale of 0 to 10. A score of '0' indicates that the patient is free of pain whereas a score of '10' indicates that patient has severe pain.

    Measured: From end of anaesthesia till 24-hours postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jun 2018
  2. Study start10 Oct 2018
  3. Primary completion2 Mar 2028 (estimated)
  4. Study completion2 Mar 2028 (estimated)

Why it stopped: Due to Coronavirus infection decrease in elective case list , also lack of response from other centers

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
2000- patients aged 18-65 years scheduled for elective surgery under general anaesthesia will be randomly allocated to one of the following two groups: Group I \[BIS Guided Group, n=1000\]: GA will be monitored and controlled with Bi-spectral index (BIS). Group II \[ETAG Guided Group, n=1000\]: GA will be monitored and controlled with end-tidal anaesthesia gas concentration (ETAG).
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
2,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03571945
Sponsor's protocol ID
EC/09/17/1253
Status last verified
Apr 2026
First submitted
19 Jun 2018
Last updated
27 Apr 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Bi-spectral Index (BIS QUATRO REF #186-0106) and End tidal anaesthesia gas concentration (ETAG) in people with Intraoperative Awareness, run by Sir Ganga Ram Hospital at 5 sites in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 27 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of intraoperative awareness (time frame: From end of anaesthesia till 30-days postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in